In conclusion, our studies, to our knowledge for the first time, provided evidence of the antimetastatic activity of PTX in counteracting TNF-α/TGF-β1-induced EMT in cervical cancer cells via the NF-κB/TGF-β1/SERPINE1. The gene discussed is NFKB1; the disease is cervical cancer.